Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers Caitlin W. Hicks, MD, MS, Shalini Selvarajah, MD, MPH, Nestoras Mathioudakis, MD, Bruce A. Perler, MD, Julie A. Freischlag, MD, James H. Black, MD, Christopher J. Abularrage, MD Journal of Vascular Surgery Volume 60, Issue 5, Pages 1247-1254.e2 (November 2014) DOI: 10.1016/j.jvs.2014.05.009 Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 1 Risk-adjusted annual cumulative costs for inpatient treatment of diabetic foot ulcers in the United States increased significantly from 2005 to 2010 (P < .001). Journal of Vascular Surgery 2014 60, 1247-1254.e2DOI: (10.1016/j.jvs.2014.05.009) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 2 Multivariable risk-adjusted analysis demonstrated that the main factors contributing to the escalating cost per patient hospitalization for diabetic foot ulcers included increased patient comorbidities, open revascularization, endovascular revascularization, and minor amputations (P < .001). Osteomyelitis, diagnostic testing, and major amputations did not significantly affect cost increases after risk-adjustment (P = not significant). Journal of Vascular Surgery 2014 60, 1247-1254.e2DOI: (10.1016/j.jvs.2014.05.009) Copyright © 2014 Society for Vascular Surgery Terms and Conditions